Journal of Lipid Research, Vol 22, 323-338, Copyright © 1981 by Lipid Research, Inc.

ARTICLES

Cholesterol metabolism in hypothyroidism and hyperthyroidism in man

JJ Abrams and SM Grundy

Studies were carried out on cholesterol metabolism in 11 nonobese patients and 16 obese patients with hypothyroidism and 13 with hyperthyroidism. The patients underwent several investigations under metabolic ward conditions. Hypothyroid patients usually had an increase in low density lipoprotein (LDL)-cholesterol. Several mechanisms may have combined to cause a high LDL. For instance, the obese hypothyroid patients had an increase in cholesterol synthesis. Absorption of cholesterol also was increased frequently. However, other mechanisms not explored in this study probably contributed to most of the fall in LDL-cholesterol. Treatment of hypothyroid patients produced the expected fall in LDL. One possible mechanism could be that thyroid hormones enhance the conversion of cholesterol into bile acids; this mechanism has been suggested by other workers from animal studies. However, no evidence was obtained in either hypothyroid or hyperthyroid patients that thyroid hormones alter synthesis of bile acids. On the other hand, the hormones appeared to increase the synthesis of cholesterol. Patients with hypothyroidism frequently had supersaturated bile. The cause was mostly an enhanced secretion of biliary cholesterol associated with a tendency to obesity and increased synthesis of cholesterol. In contrast, the usually thin hyperthyroid patients did not have supersaturated bile. The studies show that thyroid hormones a) influence LDL-cholesterol by an action on the catabolism of LDL- independent of alterations in synthesis, catabolism, absorption, or excretion: b) stimulate synthesis of cholesterol; and c) affect biliary lipid metabolism in large part by influencing energy balance and cholesterol synthesis.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				M. D. Erion, E. E. Cable, B. R. Ito, H. Jiang, J. M. Fujitaki, P. D. Finn, B.-H. Zhang, J. Hou, S. H. Boyer, P. D. van Poelje, et al. From the Cover: Targeting thyroid hormone receptor-beta agonists to the liver reduces cholesterol and triglycerides and improves the therapeutic index PNAS, September 25, 2007; 104(39): 15490 - 15495. [Abstract] [Full Text] [PDF]

				V. A. B. Drover and L. B. Agellon Regulation of the Human Cholesterol 7{alpha}-Hydroxylase Gene (CYP7A1) by Thyroid Hormone in Transgenic Mice Endocrinology, February 1, 2004; 145(2): 574 - 581. [Abstract] [Full Text] [PDF]

				D.-J. Shin and T. F. Osborne Thyroid Hormone Regulation and Cholesterol Metabolism Are Connected through Sterol Regulatory Element-binding Protein-2 (SREBP-2) J. Biol. Chem., September 5, 2003; 278(36): 34114 - 34118. [Abstract] [Full Text] [PDF]

				H. Gullberg, M. Rudling, D. Forrest, B. Angelin, and B. Vennström Thyroid Hormone Receptor {beta}-Deficient Mice Show Complete Loss of the Normal Cholesterol 7{alpha}-Hydroxylase (CYP7A) Response to Thyroid Hormone but Display Enhanced Resistance to Dietary Cholesterol Mol. Endocrinol., November 1, 2000; 14(11): 1739 - 1749. [Abstract] [Full Text]

				N. Tagawa, J. Tamanaka, A. Fujinami, Y. Kobayashi, T. Takano, S. Fukata, K. Kuma, H. Tada, and N. Amino Serum Dehydroepiandrosterone, Dehydroepiandrosterone Sulfate, and Pregnenolone Sulfate Concentrations in Patients with Hyperthyroidism and Hypothyroidism Clin. Chem., April 1, 2000; 46(4): 523 - 528. [Abstract] [Full Text] [PDF]

				V. Sundaram, A. N. Hanna, L. Koneru, H. A. I. Newman, and J. M. Falko Both Hypothyroidism and Hyperthyroidism Enhance Low Density Lipoprotein Oxidation J. Clin. Endocrinol. Metab., October 1, 1997; 82(10): 3421 - 3424. [Abstract] [Full Text] [PDF]